WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 531961
Description: IBC 293 is a highly selective agonist for GPR109B (HM74), human orphan G-protein-coupled receptor expressed in adipocytes. IBC 293 is selective for GPR109B over niacin receptor GPR109A (HM74A).
MedKoo Cat#: 531961
Name: IBC 293
Chemical Formula: C10H11N3O2
Exact Mass: 205.0851
Molecular Weight: 205.22
Elemental Analysis: C, 58.53; H, 5.40; N, 20.48; O, 15.59
IBC 293, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received
Synonym: IBC 293; IBC293; IBC-293.
IUPAC/Chemical Name: 1-propan-2-ylbenzotriazole-5-carboxylic acid
InChi Key: RUTVRAJKELSHCC-UHFFFAOYSA-N
InChi Code: InChI=1S/C10H11N3O2/c1-6(2)13-9-4-3-7(10(14)15)5-8(9)11-12-13/h3-6H,1-2H3,(H,14,15)
SMILES Code: O=C(C1=CC=C(N(C(C)C)N=N2)C2=C1)O
The following data is based on the product molecular weight 205.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Mazzola E, Cheng SC, Parmigiani G. The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2013 Jan;137(1):315-8. doi: 10.1007/s10549-012-2345-5. PubMed PMID: 23184082; PubMed Central PMCID: PMC3836600.